Collectively, TSCP exerts prominent protective effects against acute pharyngitis through dual mechanisms: suppression of the inflammatory response via the PI3K/AKT/NF‐κB pathway, and direct broad‐spectrum antibacterial and anti‐biofilm activities <i>in vitro</i>. This evidence concerns the gene AKT1 and acute pharyngitis.